Incretin‐based glucose‐lowering medications and the risk of acute pancreatitis and/or pancreatic cancer: Reassuring data from cardio‐vascular outcome trials
Year: 2017
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12981
Institutions: St. Josef-Hospital, Ruhr University Bochum
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2607170437